Efficacy of antihypertensive therapy in decreasing renal and cardiovascular complications in diabetes mellitus

Nephrology Dialysis Transplantation

Volumn 13, Issue SUPPL. 8, 1998, Pages 44-48

  Nosadini, R ^a   Abaterusso, C ^b   Dalla Vestra, M ^b   Bortoloso, E ^b   Saller, A ^b   Bruseghin, M ^b   Sfriso, A ^b   Trevisan, M ^b  

^a UNIVERSITY OF SASSARI   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Angiotensin converting enzyme inhibitors; Calcium channel blockers; Cardiovascular complications; Diabetes mellitus; Diabetic nephropathy

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE;

ANTIHYPERTENSIVE THERAPY; CONFERENCE PAPER; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0031754421     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.suppl_8.44     Document Type: Conference Paper

References (20)

1. Gerstein HC, Yusuf S. Dysglycaemia and risk of cardiovascular disease. Lancet 1996; 347: 949-950
2. Zimmet PZ, Alberti KGMM. The changing face of macrovascular disease in non-insulin-dependent diabetes mellitus: an epidemic in progress. Lancet 1997; 350 [Suppl 1]: 1-4
3. Nathan DM, Meigs J, Singer DE. The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet is... or is it? Lancet 1997; 350 [Suppl 1]: 4-9
4. Eastman RC, Keen H. The impaet of cardiovascular disease on people with diabetes: the potential for prevention. Lancet 1997; 350 [Suppl I]: 29-32
5. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1201
6. Donahue RP, Abbott RD, Reed DM, Yano K. Post challenge glucose concentration and coronary heart disease in men of Japanese ancestry. Diabetes 1987; 36: 689-692
7. Singer DE, Nathan D, Anderson K, Wilson P, Evans JC. Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 1992; 41: 202-208
8. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
9. Moss SE, Klein R, Klein BEF. Cause-specific mortality in a population based study of diabetes. Am J Public Health 1991; 81: 1158-1162
10. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson K and the Scandinavian Simvastatin Survival Study [4S] Group. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study [4S]. Diabetes Care 1997; 20: 614-620
11. Jerums G, Allen TJ, Tsalamandris C, Cooper ME, for the MDNSG. Angiotensin converting enzyme inhibition and calcium channel blockade in incipient diabetic nephropathy. Kidney Int 1992; 41: 904-911
12. Chan JCN, Cockram CS, Nicholls MG, Cheung CK, Swaminathan R. Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hyper-tension: one year analysis. Br Med J 1992; 305: 981-985
13. Mimram A, Insua A, Ribstein J, Bringer J, Monnier L. Comparative effect of captopril and nifedipine in normotensive insulin patients with incipient diabetic nephropathy. Diabetes Care 1988; 11: 850-853
14. Baba T, Murabayashi S, Takabe K. Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 diabetic patients with microalbuminuria: a randomized controlled trial. Diabetologia 1989; 32: 40-44
15. Bakris GL, Copley JB, Vicknair N, Sadler R, Leurgans S. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. Kidney Int 1996; 50: 1641-1650
16. Velussi M, Brocco E, Frigato F, Nosadini R et al. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients. Diabetes 1996; 45: 216-222
17. Rossing P, Tarnow L, Boelskifte S, Jensen BR, Nielsen FS, Parving HH. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive JDDM patients with diabetic nephropathy during the first year of treatment. Diabetes 1997; 46: 481-487
18. Crepaldi G, Carta Q, Deferrari G, Nosadini R et al. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. Diabetes Care 1998; 21: 104-110
19. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446.
20. Byington RP, Craven TE, Furberg CD, Pahor M. Isradipine, raised glycosylated haemoglobin, and risk of cardiovascular events. Lancet 1997; 350: 1075-1076